An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps
Clinical trial NCT07424144 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07424144
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-12
- Primary completion
- 2027-02-17
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.